Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQshaematology-oncology-and-transfusion

Paeds SAQs · haematology-oncology-and-transfusion

Hereditary spherocytosis and membrane disorders — formative SAQs

Formative SAQs on hereditary spherocytosis and the inherited red cell membrane disorders: the clinical triad and blood film, the eosin-5-maleimide binding test, the severity spectrum and management with folate and transfusion, splenectomy timing and technique, the pre-splenectomy vaccination and post-splenectomy prophylaxis bundle, the parvovirus B19 aplastic crisis, and the critical exclusion of hereditary stomatocytosis before any splenectomy.

20 marks30 min5 min readVerification in progress

Target exams

RACP General PaediatricsMRCPCH ClinicalABP General Pediatrics
On this page
Study tools

Target exams

RACP General PaediatricsMRCPCH ClinicalABP General Pediatrics
Prompt
Hereditary spherocytosis

SAQ 1 (10 marks)

A seven-year-old girl is referred for investigation of chronic fatigue, pallor and intermittent yellowing of the eyes. Her mother had a splenectomy at age twelve and a cholecystectomy at twenty-eight. On examination she has scleral icterus and a spleen palpable four centimetres below the costal margin. Her haemoglobin is 84 g per litre, mean cell haemoglobin concentration is 370 g per litre, reticulocyte count is twelve per cent, unconjugated bilirubin is 42 micromoles per litre, and the blood film shows numerous small dense spherocytes. The direct antiglobulin test is negative. [1]

  1. Give the diagnosis, explain the pathophysiology, and describe the confirmatory investigation of choice. (3) [1] [2]
  2. Outline the definitive management, including the role and timing of splenectomy and the decision between total and partial splenectomy. (4) [2] [4]
  3. Describe the pre-splenectomy preparation and the lifelong post-splenectomy precautions that this child must receive. (3) [2] [5]

Model answer — SAQ 1

(1) Diagnosis, pathophysiology and confirmation (3). The diagnosis is hereditary spherocytosis, supported by the family history of splenectomy and cholecystectomy, the triad of anaemia, jaundice and splenomegaly, the raised mean cell haemoglobin concentration, the reticulocytosis, the unconjugated hyperbilirubinaemia, the spherocytes on the blood film, and crucially the negative direct antiglobulin test excluding autoimmune haemolysis. The pathophysiology is a defect in the vertical protein linkages of the red cell membrane — most commonly ankyrin deficiency — that destabilises the lipid bilayer-to-cytoskeleton tether. The membrane blebs off, the cell loses surface area without losing volume, the surface-to-volume ratio falls, and the biconcave disc becomes a dense, rigid spherocyte that cannot deform through the splenic cords and is destroyed by splenic macrophages. The confirmatory investigation of choice is the eosin-5-maleimide binding test, a flow cytometric assay showing reduced fluorescence in hereditary spherocytosis due to reduced band 3 content, with a sensitivity of about ninety-three per cent and specificity of about ninety-eight per cent. [1] [2]

(2) Definitive management and splenectomy (4). Every child receives folic acid supplementation to support the expanded erythropoiesis, at a dose of 5 mg daily in this age group. For her moderate disease with symptomatic haemolysis and a haemoglobin of 84 g per litre, splenectomy is indicated. Splenectomy is the only curative treatment for the haemolysis: it removes the organ of red cell destruction, so the haemolysis resolves and the haemoglobin normalises, though the underlying membrane defect persists and the cells remain spherocytes. The splenectomy should be deferred until at least six years of age, which she has reached, and the laparoscopic approach is preferred. The choice between total and partial splenectomy is debated: total splenectomy provides superior haematological outcomes with complete elimination of the haemolysis, but it removes all splenic immune function and carries the full risk of overwhelming post-splenectomy infection. Partial splenectomy preserves some immune function but carries a higher rate of reoperation and recurrence. The recent systematic review and meta-analysis favours total splenectomy for definitive cure, with partial splenectomy reserved for younger children with severe disease who cannot wait until six years or for families who prioritise immune preservation. Concomitant cholecystectomy should be considered if gallstones are present. [2] [4]

(3) Pre-splenectomy preparation and lifelong precautions (3). At least two weeks before splenectomy she must complete the vaccination bundle against encapsulated organisms: pneumococcal (conjugate and polysaccharide as appropriate for age), meningococcal (ACWY and B), and Haemophilus influenzae type b. After splenectomy she requires lifelong antibiotic prophylaxis with penicillin V at 250 mg twice daily in this age group, or erythromycin if allergic. The family must receive a febrile-illness action plan: any fever is an emergency requiring immediate medical assessment and parenteral antibiotics, because the risk of overwhelming post-splenectomy infection is highest in the first two postoperative years and in young children. She should carry a medic alert device and a patient-held information card, and her vaccination schedule must be kept up to date through adolescence and into adulthood. [2] [5]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Perrotta S, Gallagher PG, Mohandas N Hereditary spherocytosis. Lancet, 2008.PMID 18940465
  2. [2]Bolton-Maggs PH, Langer JC, Iolascon A, et al. Guidelines for the diagnosis and management of hereditary spherocytosis--2011 update. Br J Haematol, 2012.PMID 22055020
  3. [3]Andolfo I, Russo R, Gambale A, et al. Hereditary stomatocytosis: An underdiagnosed condition. Am J Hematol, 2018.PMID 28971506
  4. [4]Casale M, Perrotta S Splenectomy for hereditary spherocytosis: complete, partial or not at all? Expert Rev Hematol, 2011.PMID 22077527
  5. [5]Liu Y, Jin S, Xu R, et al. Hereditary spherocytosis before and after splenectomy and risk of hospitalization for infection. Pediatr Res, 2023.PMID 35915237
  6. [6]Christensen RD, Yaish HM, Gallagher PG A pediatrician's practical guide to diagnosing and treating hereditary spherocytosis in neonates. Pediatrics, 2015.PMID 26009624
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousHaemolytic anaemia: diagnostic approach: SAQhaematology-oncology-and-transfusionNextIron deficiency anaemia — formative SAQshaematology-oncology-and-transfusion